Indication

Growth failure in child with short stature homeobox-containing gene (SHOX) deficiency

Growth failure in a child with short stature homeobox-containing gene (SHOX) deficiency is a pediatric skeletal growth disorder caused by haploinsufficiency of the *SHOX* gene located on the pseudoautosomal region of the sex chromosomes. Read more about Growth failure in child with short stature homeobox-containing gene (SHOX) deficiency

2 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Growth failure in child with short stature homeobox-containing gene (SHOX) deficiency therapies.

Showing 1–2 of 2 drugs

Filter & compare in the drug finder →Opens the drug finder with Growth failure in child with short stature homeobox-containing gene (SHOX) deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Growth failure in child with short stature homeobox-containing gene (SHOX) deficiency.

Growth failure in a child with short stature homeobox-containing gene (SHOX) deficiency is a pediatric skeletal growth disorder caused by haploinsufficiency of the *SHOX* gene located on the pseudoautosomal region of the sex chromosomes.

This genetic disruption impairs chondrocyte proliferation and differentiation within the epiphyseal growth plates of long bones.

Affected children present with subnormal linear height velocity and significantly reduced adult height potential, which may manifest as isolated short stature or as part of a dyschondrosteosis phenotype characterized by mesomelic limb shortening, muscular hypertrophy, and characteristic wrist alterations such as Madelung deformity.

Personalize your experience

Follow Growth failure in child with short stature homeobox-containing gene (SHOX) deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it